|4Mar 1, 5:01 PM ET

Coiante Scott M 4

4 · Aprea Therapeutics, Inc. · Filed Mar 1, 2022

Insider Transaction Report

Form 4
Period: 2022-02-25
Coiante Scott M
SVP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-02-25$1.74/sh14,817$25,78276,649 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 32,167 restricted stock units.

Documents

1 file
  • 4
    tm227953-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT